| __timestamp | Regeneron Pharmaceuticals, Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 504755000 | 72471000 |
| Thursday, January 1, 2015 | 838526000 | 89204000 |
| Friday, January 1, 2016 | 1177697000 | 106010000 |
| Sunday, January 1, 2017 | 1320433000 | 137905000 |
| Monday, January 1, 2018 | 1556200000 | 159888000 |
| Tuesday, January 1, 2019 | 1834800000 | 158425000 |
| Wednesday, January 1, 2020 | 1346000000 | 200677000 |
| Friday, January 1, 2021 | 1824900000 | 304759000 |
| Saturday, January 1, 2022 | 2115900000 | 377221000 |
| Sunday, January 1, 2023 | 2631300000 | 336361000 |
| Monday, January 1, 2024 | 2954400000 |
Infusing magic into the data realm
In the competitive world of pharmaceuticals, understanding the financial strategies of industry leaders is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Regeneron Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc. from 2014 to 2023. Over this period, Regeneron has seen a staggering 421% increase in SG&A expenses, reflecting its aggressive expansion and marketing strategies. In contrast, Supernus Pharmaceuticals, Inc. has experienced a 364% rise, indicating a more measured growth approach.
These trends underscore the diverse strategies employed by these companies in navigating the pharmaceutical landscape.
Selling, General, and Administrative Costs: Gilead Sciences, Inc. vs Regeneron Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Vertex Pharmaceuticals Incorporated and Regeneron Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Takeda Pharmaceutical Company Limited
Regeneron Pharmaceuticals, Inc. or Opthea Limited: Who Manages SG&A Costs Better?
Regeneron Pharmaceuticals, Inc. vs Jazz Pharmaceuticals plc: SG&A Expense Trends
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Soleno Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Regeneron Pharmaceuticals, Inc. and Veracyte, Inc.
SG&A Efficiency Analysis: Comparing Alnylam Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.
Genmab A/S and Supernus Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of BioMarin Pharmaceutical Inc. and Supernus Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Lantheus Holdings, Inc. and Supernus Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Perrigo Company plc and Supernus Pharmaceuticals, Inc.